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Elevated blood pressure (BP) is a growing burden worldwide, leading to over 10 million deaths each year. May
Measurement Month (MMM) is a global initiative aimed at raising awareness of high BP and to act as a temporary
solution to the lack of screening programs worldwide. Hypertension is a global health concern for developing
countries. In Pakistan, apart from few population-based studies which evaluated the prevalence of hyperten-
sion, there is no current nationally representative study (the latest nationwide survey was conducted more than
two decades ago). Pakistan Hypertension League, in accordance with the International Society of Hypertension
directive under the banner of the May Measurement Month 2017 (MMM17) campaign, carried out a nationwide
cross-sectional survey of volunteers aged 18 in May 2017 through its 14 regional chapters. Blood pressure mea-
surement recorded through digital apparatus, the definition of hypertension (140/90mmHg or being on BP-
lowering treatment) and statistical analysis followed the standard MMM protocol. A total of 5333 individuals
were screened during the MMM17 campaign with mean age 45.0 (11.6). Males had a higher rate (66.3%,
n¼ 3536) in those screened than females (33.0%, n¼ 1757). A total of 55.2% (n¼ 2943) people had hyperten-
sion. This result shows very high rates of hypertension in Pakistani people. Therefore, there is an urgent need
for federal implementation of BP screening as well as awareness programs across the nation.
Introduction
High blood pressure (BP) is a major modifiable risk factor
contributing to the current pandemic of cardiovascular dis-
eases (CVD). This is particularly challenging for developing
countries that are estimated to house three-fourths of the
global burden of patients with hypertension in the coming
few decades.1 Despite the well-established benefits of low-
ering BP control and thorough existing guidelines, even in
parts of the developed world less than one-third of the
patients achieve recommended BP values of <140/90.2
Projected increase in CVD is expected to be much greater
in South Asia than in any other region worldwide,3 where it
is expected to more than double over the next 20years.4
The burden of coronary heart disease (CHD) in South Asians
extends beyond regional concerns, as CHD mortality and
morbidity remain higher in immigrant South Asians living in
western regions compared with native western pop-
ulations.5 Data from the developing countries, particularly
in Pakistan, are barely emerging in this regard. The
Pakistan Hypertension League (PHL), as a member of the
International Society of Hypertension, got involved with
May Measurement Month (MMM). The objective of this sur-
vey was to raise awareness of BP in a Pakistani population.
Methods
The Pakistan Hypertension League, under the banner of
MMM, conducted a cross-sectional survey by involving all of
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its 14 regional chapters throughout Pakistan. More than
150 volunteers were selected to conduct this survey with
the help of the pharmaceutical industry and were trained
at PHL regional chapters. All of the 14 sites’ teammembers
were supervised by the regional chapter coordinators.
Screening camps were arranged in the month of May 2017
by the PHL at public places, hospital visiting areas, and at
various institutions, to allow the general public to be
screened for their BP’s. After taking informed consent, re-
search volunteers at every camp enrolled individuals aged
18 or above. An MMM pre-piloted data tool was used to re-
cord the demographic data including age and gender. Blood
pressures of every individual were recorded in the sitting
position, using an OMRON digital BP apparatus.
Hypertension was defined according to the JNC7 guide-
lines.6 A subject was classified as having hypertension if
the BP reading was140/90mmHg or in those takingmedi-
cation for high BP. Study participants’ identities were kept
anonymous and their privacy was ensured. All data were
coded and analysed by the MMM statistics team. Mean 6 1
standard deviation (SD) were computed for all continuous
data, and frequencies were calculated for categorical
variables.
Results
General characteristics of study participants are presented
in Table 1. There were 5333 participants screened in this
study. Of these, 3536 were males (66.3%) and 1757 were
females (33.0%). The mean age of study participants was
45.0 (SD 11.6) years. Age and gender standardized mean
systolic BP (SBP) was 133.2mmHg and diastolic BP was
84.8mmHg (Table 2). A total of 55.2% (2943/5333) partici-
pants had hypertension. This survey shows the very high
prevalence of hypertension in this Pakistani population.
Discussion
Results of this survey show a high proportion (55.2%) of our
study group had hypertension with a mean age of
45.0years. The incidence of cardiovascular complications
are rising sharply in this region therefore control of BP is ex-
tremely important in the Pakistani population.7,8
In 2014–15, Pakistan Health Research Council conducted
a survey on Non-Communicable Risk Factors in Pakistan,
which shows about 45.3% people never got their BP
checked, almost 37% of the population had Stage I hyper-
tension and 15.9% had Stage II hypertension.9 Modifiable
risk factors of CVD such as hypercholesterolaemia and sed-
entary life style also need to be evaluated as they are asso-
ciated with high BP. Studies have shown that increased
cholesterol levels alter the peripheral and the renal vascu-
lar tone increasing the progression of high-normal BP to hy-
pertension (BP > 140/>90).10 Similarly, physical inactivity
raises the SBP, while elevating total cholesterol levels as
well.11,12
In Pakistan, with a population of 197million, it is very im-
portant to develop more effective strategies for better
high BP detection and management to achieve adequate
therapeutic control of BP. It will include national education
campaigns to increase the awareness about high BP, con-
trolling modifiable risk factors, better patient counselling
to improve lifestyle, and adherence to treatment. Also
large scale studies at a national level are needed to evalu-
ate the association of BP with modifiable risk factors in the
Pakistani population. This will help in the development of
better and effective strategies to prevent and treat hyper-
tension in the Pakistani population and reduce the increas-
ing burden of CVD in this region.
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